Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer. [electronic resource]
Producer: 20050215Description: 5769-76 p. digitalISSN:- 1078-0432
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Hormonal -- therapeutic use
- Breast Neoplasms -- drug therapy
- Carcinoma, Ductal, Breast -- drug therapy
- Carcinoma, Lobular -- drug therapy
- Cell Proliferation
- Drug Resistance, Neoplasm
- Estrogen Receptor beta -- metabolism
- Female
- Humans
- Immunoenzyme Techniques
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Recurrence, Local -- drug therapy
- Predictive Value of Tests
- Retrospective Studies
- Survival Rate
- Tamoxifen -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.